{
    "hands_on_practices": [
        {
            "introduction": "Understanding how a drug interacts with its target begins with quantifying its binding affinity. This exercise guides you from the first principles of chemical equilibrium to derive the fundamental equation that governs single-site drug-receptor binding. By analyzing a hypothetical dataset, you will practice determining key parameters like the dissociation constant ($K_D$) and see how these concepts directly inform the design of more complex experiments.",
            "id": "4551629",
            "problem": "A reversible drug-receptor system is studied in membrane preparations using a radiolabeled ligand. At equilibrium, the binding reaction is drug $\\mathrm{D}$ plus receptor $\\mathrm{R}$ forming complex $\\mathrm{DR}$, and the dissociation constant $K_{D}$ is defined from the law of mass action and the definitions of the rate constants. The total receptor concentration is conserved. A saturation binding experiment (with non-specific binding subtracted) yields the following specific binding data, where the ligand concentration is $[L]$ and the measured bound ligand is $B$:\n- $[L]=\\{\\,0.5,\\,1,\\,2,\\,5,\\,10,\\,20,\\,50,\\,100\\,\\}\\ \\text{nM}$,\n- $B=\\{\\,9.09,\\,16.67,\\,28.57,\\,50.00,\\,66.67,\\,80.00,\\,90.91,\\,95.24\\,\\}\\ \\text{fmol}\\ \\text{mg}^{-1}$.\n\nTasks:\n1. Using only the law of mass action at equilibrium, conservation of receptors, and the definition of the dissociation constant $K_{D}$, justify that the data are consistent with a single, non-cooperative binding site model and derive from first principles the expression for the fractional receptor occupancy $f$ as a function of $[L]$ and $K_{D}$.\n2. Using your derived expression, compute the fractional occupancy $f$ at $[L]=K_{D}$, $[L]=0.1\\,K_{D}$, and $[L]=10\\,K_{D}$. Report these three values as exact simplified fractions in a single row vector. Do not include units; $f$ is dimensionless.\n3. Based on your derivation and the saturation binding data, explain how you would choose an appropriate tracer concentration $[L]$ for a competitive binding assay intended to estimate inhibitor affinity, and justify your choice using quantitative reasoning tied to your expression for $f$.\n\nFor item $2$, provide the final answer as a row vector and express each occupancy as an exact fraction. No rounding is required. The explanatory discussion requested in item $3$ should not be included in the final answer but should be fully developed in your solution.",
            "solution": "The problem is valid as it is scientifically grounded in the principles of pharmacology and chemical kinetics, well-posed, and contains sufficient, consistent data to derive the requested expressions and justify the conclusions.\n\nThe solution is partitioned into the three tasks specified in the problem statement.\n\nTask 1: Justification of the model and derivation of the fractional occupancy expression.\n\nThe problem describes a reversible binding reaction between a drug (ligand, $L$) and a receptor ($R$) to form a drug-receptor complex ($LR$). Note that the problem text uses $D$ for drug but $[L]$ for ligand concentration; we will use $L$ for the ligand species for consistency. The reaction is:\n$$ L + R \\underset{k_{off}}{\\stackrel{k_{on}}{\\rightleftharpoons}} LR $$\nwhere $k_{on}$ is the association rate constant and $k_{off}$ is the dissociation rate constant.\n\nAccording to the law of mass action, at equilibrium, the rate of formation of the complex equals the rate of its dissociation:\n$$ \\text{Rate}_{association} = \\text{Rate}_{dissociation} $$\n$$ k_{on} [L] [R] = k_{off} [LR] $$\nHere, $[L]$, $[R]$, and $[LR]$ represent the molar concentrations of the free ligand, free receptor, and ligand-receptor complex, respectively.\n\nThe dissociation constant, $K_D$, is defined as the ratio of the dissociation rate constant to the association rate constant:\n$$ K_D = \\frac{k_{off}}{k_{on}} $$\nSubstituting this definition into the equilibrium equation gives:\n$$ K_D = \\frac{[L][R]}{[LR]} $$\nThis equation relates the concentrations of the three species at equilibrium.\n\nThe problem states that the total receptor concentration is conserved. Let the total receptor concentration be $R_T$. This means that any receptor is either free ($R$) or bound in a complex ($LR$):\n$$ R_T = [R] + [LR] $$\nThis conservation law is a key principle for a system with a single, non-cooperative binding site.\n\nThe fractional receptor occupancy, $f$, is defined as the fraction of the total receptors that are bound by the ligand:\n$$ f = \\frac{[LR]}{R_T} $$\nTo derive an expression for $f$ in terms of $[L]$ and $K_D$, we must eliminate $[R]$ and $[LR]$ from the equations. From the conservation law, we can express the free receptor concentration as:\n$$ [R] = R_T - [LR] $$\nSubstitute this into the expression for $K_D$:\n$$ K_D = \\frac{[L](R_T - [LR])}{[LR]} $$\nNow, we solve this equation for the term $[LR]$:\n$$ K_D [LR] = [L] R_T - [L] [LR] $$\n$$ K_D [LR] + [L] [LR] = [L] R_T $$\n$$ [LR] (K_D + [L]) = [L] R_T $$\n$$ [LR] = \\frac{[L] R_T}{K_D + [L]} $$\nThis expression gives the concentration of bound receptors. To find the fractional occupancy $f$, we divide by $R_T$:\n$$ f = \\frac{[LR]}{R_T} = \\frac{1}{R_T} \\left( \\frac{[L] R_T}{K_D + [L]} \\right) $$\n$$ f = \\frac{[L]}{K_D + [L]} $$\nThis is the Hill-Langmuir equation for a system with a Hill coefficient of $1$, which is the mathematical model for single-site, non-cooperative binding. The derivation from the law of mass action and receptor conservation thus confirms that these principles lead directly to this model.\n\nTo justify that the provided data are consistent with this model, we relate the measured bound ligand, $B$, to the model parameters. The specific binding $B$ is directly proportional to the concentration of the ligand-receptor complex, $[LR]$. The maximum binding, $B_{max}$, occurs when all receptors are saturated (i.e., $[LR] \\to R_T$ as $[L] \\to \\infty$), so $B$ is related to $B_{max}$ in the same way that $[LR]$ is related to $R_T$. Therefore, $B = f \\cdot B_{max}$.\n$$ B = B_{max} \\frac{[L]}{K_D + [L]} $$\nWe can check if the data fit this equation. A key feature of this model is that when the ligand concentration equals the dissociation constant, $[L]=K_D$, the binding is half-maximal. From the data table, for $[L] = 5 \\text{ nM}$, the measured binding is $B = 50.00 \\text{ fmol mg}^{-1}$. The binding values appear to approach a maximum around $100 \\text{ fmol mg}^{-1}$ (e.g., at $[L]=100 \\text{ nM}$, $B=95.24 \\text{ fmol mg}^{-1}$). If we hypothesize that $B_{max} = 100 \\text{ fmol mg}^{-1}$, then at $B=50 \\text{ fmol mg}^{-1}$, we have $B = B_{max}/2$. This occurs at $[L] = 5 \\text{ nM}$, which implies that $K_D = 5 \\text{ nM}$.\n\nLet's test this hypothesis ($K_D=5 \\text{ nM}$, $B_{max}=100 \\text{ fmol mg}^{-1}$) with another data point, for instance, $[L]=10 \\text{ nM}$:\n$$ B = 100 \\frac{10}{5 + 10} = 100 \\frac{10}{15} = 100 \\left(\\frac{2}{3}\\right) \\approx 66.67 \\text{ fmol mg}^{-1} $$\nThis matches the experimental value. Let's check $[L]=2 \\text{ nM}$:\n$$ B = 100 \\frac{2}{5 + 2} = 100 \\frac{2}{7} \\approx 28.57 \\text{ fmol mg}^{-1} $$\nThis also matches the experimental value. The perfect agreement across the dataset confirms that the data are consistent with a single, non-cooperative binding site model with $K_D = 5 \\text{ nM}$ and $B_{max} = 100 \\text{ fmol mg}^{-1}$.\n\nTask 2: Calculation of fractional occupancy at specific ligand concentrations.\n\nUsing the derived expression $f = \\frac{[L]}{K_D + [L]}$:\n\nCase 1: $[L] = K_D$\n$$ f = \\frac{K_D}{K_D + K_D} = \\frac{K_D}{2 K_D} = \\frac{1}{2} $$\nThis confirms the definition of $K_D$ as the ligand concentration that results in $50\\%$ receptor occupancy.\n\nCase 2: $[L] = 0.1 K_D$\n$$ f = \\frac{0.1 K_D}{K_D + 0.1 K_D} = \\frac{0.1 K_D}{1.1 K_D} = \\frac{0.1}{1.1} = \\frac{1}{11} $$\n\nCase 3: $[L] = 10 K_D$\n$$ f = \\frac{10 K_D}{K_D + 10 K_D} = \\frac{10 K_D}{11 K_D} = \\frac{10}{11} $$\n\nThese three values, expressed as exact simplified fractions, are $\\frac{1}{2}$, $\\frac{1}{11}$, and $\\frac{10}{11}$.\n\nTask 3: Choice of tracer concentration for a competitive binding assay.\n\nA competitive binding assay is used to determine the affinity of an unlabeled inhibitor by measuring its ability to displace a labeled tracer ligand from its receptor. The primary result is an $\\text{IC}_{50}$ value, which is the concentration of inhibitor required to displace $50\\%$ of the specifically bound tracer. The inhibitor's true affinity, its dissociation constant $K_i$, is then calculated from the $\\text{IC}_{50}$ using the Cheng-Prusoff equation:\n$$ K_i = \\frac{\\text{IC}_{50}}{1 + \\frac{[L]}{K_D}} $$\nwhere $[L]$ is the concentration of the tracer ligand and $K_D$ is its dissociation constant.\n\nThe choice of tracer concentration $[L]$ is crucial and involves a trade-off between signal strength and assay sensitivity.\n\n1.  **If $[L] \\gg K_D$:** For example, if we choose $[L] = 10 K_D$, the fractional occupancy is high ($f = 10/11 \\approx 91\\%$). This provides a very strong signal. However, the receptors are nearly saturated, making it difficult for an inhibitor to compete. The Cheng-Prusoff equation becomes $K_i = \\text{IC}_{50} / (1+10) = \\text{IC}_{50}/11$. This means the measured $\\text{IC}_{50}$ will be $11$ times larger than the true $K_i$. The assay becomes insensitive, especially to inhibitors with moderate or low affinity, and the large correction factor can amplify experimental errors.\n\n2.  **If $[L] \\ll K_D$:** For example, if we choose $[L] = 0.1 K_D$, the fractional occupancy is low ($f = 1/11 \\approx 9\\%$). The Cheng-Prusoff equation simplifies to $K_i \\approx \\text{IC}_{50}$, which is convenient. However, the specific binding signal ($B = f \\cdot B_{max}$) is very weak. In this problem, it would be $B \\approx 9.09 \\text{ fmol mg}^{-1}$. Such a low signal may be difficult to distinguish from background noise, leading to a poor signal-to-noise ratio and imprecise measurements.\n\n3.  **If $[L] = K_D$:** This concentration is often the optimal choice.\n    *   **Signal Strength:** The fractional occupancy is $f=1/2$, so $50\\%$ of receptors are occupied. This gives a robust signal ($B = 0.5 B_{max} = 50 \\text{ fmol mg}^{-1}$ in this case), which is typically well above the noise floor of the assay, ensuring high-quality data.\n    *   **Assay Sensitivity:** With half the receptors occupied and half free, the system is maximally sensitive to perturbation by a competitive inhibitor. There is a sufficient amount of bound tracer to be displaced, and a sufficient number of free receptors for the inhibitor to bind to.\n    *   **Data Interpretation:** The Cheng-Prusoff correction is straightforward and does not unduly distort the measured value: $K_i = \\text{IC}_{50} / (1 + K_D/K_D) = \\text{IC}_{50}/2$. The measured $\\text{IC}_{50}$ is only a factor of $2$ away from the true $K_i$, which is a manageable and well-understood correction.\n\nBased on this quantitative reasoning, an appropriate choice for the tracer concentration in a competitive binding assay is a concentration equal or close to its $K_D$. Given the data provided suggest a $K_D$ of $5 \\text{ nM}$, the appropriate tracer concentration would be $[L] = 5 \\text{ nM}$.",
            "answer": "$$\\boxed{\\begin{pmatrix} \\frac{1}{2}  \\frac{1}{11}  \\frac{10}{11} \\end{pmatrix}}$$"
        },
        {
            "introduction": "While direct binding assays are essential, much of drug discovery involves assessing unlabeled compounds for their ability to compete with a known ligand. This practice challenges you to derive the celebrated Cheng-Prusoff equation, which links an inhibitor's measured half-maximal inhibitory concentration ($IC_{50}$) to its true affinity constant ($K_i$). Working through this derivation and calculation will solidify your understanding of competitive equilibrium and provide you with a critical tool for interpreting pharmacological data.",
            "id": "4551675",
            "problem": "A radioligand competition binding experiment is performed at equilibrium on a receptor system with a single, non-cooperative binding site. A tracer ligand, denoted $L$, binds the receptor $R$ reversibly according to the law of mass action with an equilibrium dissociation constant $K_D$ defined by $K_D = \\frac{[R][L]}{[RL]}$. A competitor (inhibitor) $I$ binds the same orthosteric site on $R$ (i.e., competitively) with an inhibition constant $K_i$ defined by $K_i = \\frac{[R][I]}{[RI]}$. Assume negligible ligand depletion so that free concentrations equal total concentrations, and that specific binding is proportional to the fractional occupancy of $R$ by $L$.\n\nThe half-maximal inhibitory concentration ($IC_{50}$) is defined operationally as the concentration of $I$ that reduces the specific binding of $L$ to one-half of that observed in the absence of $I$ when the free tracer concentration $[L]$ is held constant.\n\nStarting only from the equilibrium definitions above, conservation of receptor, and the law of mass action, derive an expression for $K_i$ in terms of $IC_{50}$, $[L]$, and $K_D$. Then, for a tracer with $K_D = 10\\ \\text{nM}$ used at $[L] = 10\\ \\text{nM}$, and a measured $IC_{50} = 30\\ \\text{nM}$, compute the numerical value of $K_i$. Round your numerical result to three significant figures and express it in $\\text{nM}$. Finally, based on the magnitude of $K_i$, comment in your reasoning whether the competitor exhibits high or low affinity. Your final reported answer must be the numerical value of $K_i$ only.",
            "solution": "The problem is valid as it is scientifically grounded in the principles of receptor pharmacology and the law of mass action, is well-posed with a clear objective and sufficient data, and is free from any of the flaws listed in the validation criteria. We will proceed with the derivation and calculation.\n\nThe objective is to derive an expression for the inhibition constant, $K_i$, in terms of the half-maximal inhibitory concentration, $IC_{50}$, the concentration of the tracer ligand, $[L]$, and its dissociation constant, $K_D$. This relationship is known as the Cheng-Prusoff equation.\n\nThe system involves two reversible binding equilibria occurring simultaneously at the same receptor site $R$:\n1. Binding of the tracer ligand $L$: $R + L \\rightleftharpoons RL$\n2. Binding of the competitor $I$: $R + I \\rightleftharpoons RI$\n\nThese equilibria are governed by their respective dissociation constants:\n$K_D = \\frac{[R][L]}{[RL]}$\n$K_i = \\frac{[R][I]}{[RI]}$\n\nThe total concentration of receptors, $[R]_{total}$, is the sum of free receptors and receptors bound to either the ligand or the inhibitor:\n$[R]_{total} = [R] + [RL] + [RI]$\n\nFrom the definitions of $K_D$ and $K_i$, we can express the concentrations of the bound species in terms of the free receptor concentration $[R]$:\n$[RL] = \\frac{[R][L]}{K_D}$\n$[RI] = \\frac{[R][I]}{K_i}$\n\nSubstituting these into the equation for receptor conservation:\n$[R]_{total} = [R] + \\frac{[R][L]}{K_D} + \\frac{[R][I]}{K_i}$\nFactoring out $[R]$ gives:\n$[R]_{total} = [R] \\left( 1 + \\frac{[L]}{K_D} + \\frac{[I]}{K_i} \\right)$\n\nSpecific binding of the tracer $L$ is proportional to the fractional occupancy of the receptor by $L$, denoted as $\\theta_L$. The fractional occupancy is the ratio of receptors bound to $L$ to the total number of receptors:\n$\\theta_L = \\frac{[RL]}{[R]_{total}}$\n\nSubstituting the expressions for $[RL]$ and $[R]_{total}$:\n$\\theta_L = \\frac{\\frac{[R][L]}{K_D}}{[R] \\left( 1 + \\frac{[L]}{K_D} + \\frac{[I]}{K_i} \\right)}$\n\nThe term $[R]$ cancels out, yielding the fractional occupancy of $L$ in the presence of the inhibitor $I$:\n$\\theta_L = \\frac{\\frac{[L]}{K_D}}{1 + \\frac{[L]}{K_D} + \\frac{[I]}{K_i}}$\n\nIn the absence of the inhibitor, $[I]=0$, the fractional occupancy, which we denote as $\\theta_{L,0}$, is:\n$\\theta_{L,0} = \\frac{\\frac{[L]}{K_D}}{1 + \\frac{[L]}{K_D}}$\n\nThe $IC_{50}$ is defined as the concentration of inhibitor $[I]$ that reduces the specific binding of $L$ to one-half of its value in the absence of the inhibitor. Since binding is proportional to occupancy, this means that when $[I] = IC_{50}$, the fractional occupancy $\\theta_L$ is equal to one-half of $\\theta_{L,0}$:\n$\\theta_L|_{[I]=IC_{50}} = \\frac{1}{2}\\theta_{L,0}$\n\nSubstituting the expressions for $\\theta_L$ and $\\theta_{L,0}$ into this definition:\n$\\frac{\\frac{[L]}{K_D}}{1 + \\frac{[L]}{K_D} + \\frac{IC_{50}}{K_i}} = \\frac{1}{2} \\left( \\frac{\\frac{[L]}{K_D}}{1 + \\frac{[L]}{K_D}} \\right)$\n\nAssuming $[L] \\neq 0$, the term $\\frac{[L]}{K_D}$ in the numerator on both sides can be cancelled:\n$\\frac{1}{1 + \\frac{[L]}{K_D} + \\frac{IC_{50}}{K_i}} = \\frac{1}{2 \\left( 1 + \\frac{[L]}{K_D} \\right)}$\n\nTaking the reciprocal of both sides:\n$1 + \\frac{[L]}{K_D} + \\frac{IC_{50}}{K_i} = 2 \\left( 1 + \\frac{[L]}{K_D} \\right)$\n$1 + \\frac{[L]}{K_D} + \\frac{IC_{50}}{K_i} = 2 + 2\\frac{[L]}{K_D}$\n\nNow, we solve for the term containing $K_i$:\n$\\frac{IC_{50}}{K_i} = (2 - 1) + \\left(2\\frac{[L]}{K_D} - \\frac{[L]}{K_D}\\right)$\n$\\frac{IC_{50}}{K_i} = 1 + \\frac{[L]}{K_D}$\n\nFinally, isolating $K_i$ yields the Cheng-Prusoff equation:\n$$ K_i = \\frac{IC_{50}}{1 + \\frac{[L]}{K_D}} $$\n\nNext, we calculate the numerical value of $K_i$ using the provided data:\n$K_D = 10\\ \\text{nM}$\n$[L] = 10\\ \\text{nM}$\n$IC_{50} = 30\\ \\text{nM}$\n\nSubstituting these values into the derived equation:\n$K_i = \\frac{30\\ \\text{nM}}{1 + \\frac{10\\ \\text{nM}}{10\\ \\text{nM}}}$\n$K_i = \\frac{30\\ \\text{nM}}{1 + 1}$\n$K_i = \\frac{30\\ \\text{nM}}{2}$\n$K_i = 15\\ \\text{nM}$\n\nThe problem requires rounding to three significant figures. The result is $15.0\\ \\text{nM}$.\n\nRegarding the affinity of the competitor, the inhibition constant $K_i$ is a measure of the inhibitor's binding affinity for the receptor. It is an equilibrium dissociation constant, so a lower $K_i$ value corresponds to a higher binding affinity. A $K_i$ value of $15\\ \\text{nM}$ (i.e., $15 \\times 10^{-9}\\ \\text{M}$) indicates that the competitor binds tightly to the receptor. In pharmacological terms, a ligand with nanomolar affinity is generally considered to be a high-affinity ligand.",
            "answer": "$$\\boxed{15.0}$$"
        },
        {
            "introduction": "A drug's affinity does not tell the whole story; its ability to activate a receptor and elicit a biological response is equally crucial. This advanced practice delves into the operational model of agonism to explore concepts like efficacy ($\\tau$) and the phenomenon of \"receptor reserve.\" By modeling the impact of irreversible receptor loss on both a full and a partial agonist, you will gain a quantitative appreciation for why some agonists can produce a maximal response while occupying only a fraction of receptors, a cornerstone of modern pharmacology.",
            "id": "4551662",
            "problem": "A single receptor–effector system in a tissue is described by the operational model of agonism with Hill coefficient equal to one. Let the transduction capacity of the tissue be $E_{m}$, the agonist equilibrium dissociation constant be $K_{A}$, the agonist concentration be $C$, and the operational efficacy parameter be $\\tau$. An irreversible antagonist covalently inactivates receptors, leaving a fixed proportion $q \\in (0,1)$ of functional receptors available. The intrinsic efficacy per receptor and $K_{A}$ are unchanged by the blockade.\n\nStarting from the operational model as a fundamental base, derive an expression for the maximal effect $E_{\\max}$ of a single agonist as a function of $\\tau$, and then determine how $E_{\\max}$ changes when the receptor population is irreversibly reduced to the fraction $q$. Use first principles of receptor theory to justify how $\\tau$ transforms under irreversible reduction of the receptor number.\n\nDefine the fold retention of maximal effect under irreversible blockade as $R(\\tau,q) \\equiv \\dfrac{E_{\\max}(\\text{after blockade})}{E_{\\max}(\\text{before blockade})}$. Consider two agonists acting on the same receptor–effector system: a full agonist with $\\tau_{f} = 20$ and a partial agonist with $\\tau_{p} = 0.5$. The irreversible antagonist leaves a fraction $q = 0.4$ of receptors available.\n\nCompute the single unitless quantity\n$$\n\\frac{R(\\tau_{p},q)}{R(\\tau_{f},q)}\n$$\nand report it as a pure number. Round your answer to four significant figures.",
            "solution": "The problem is valid as it is scientifically grounded in the operational model of agonism, a core concept in quantitative pharmacology. It is well-posed with a clear objective and all necessary parameters provided.\n\nThe solution is derived by first establishing the equation for the maximal effect ($E_{max}$) from the operational model, then determining how this effect changes with a reduction in receptor number, and finally calculating the requested ratio for the given agonists.\n\n**1. Derivation of Maximal Effect ($E_{max}$) from the Operational Model**\n\nThe response $E$ of a tissue to an agonist with concentration $C$ is given by the operational model equation (with a Hill coefficient of 1):\n$$ E(C) = \\frac{E_m \\tau C}{K_A + C(1+\\tau)} $$\nwhere $E_m$ is the maximum possible response of the tissue, $\\tau$ is the operational efficacy of the agonist, and $K_A$ is the agonist's equilibrium dissociation constant.\n\nThe maximal effect, $E_{max}$, is the response at a saturating concentration of the agonist, which is the limit as $C \\to \\infty$:\n$$ E_{max} = \\lim_{C \\to \\infty} E(C) = \\lim_{C \\to \\infty} \\frac{E_m \\tau C}{K_A + C(1+\\tau)} $$\nTo evaluate the limit, we divide the numerator and denominator by $C$:\n$$ E_{max} = \\lim_{C \\to \\infty} \\frac{E_m \\tau}{\\frac{K_A}{C} + (1+\\tau)} = \\frac{E_m \\tau}{0 + (1+\\tau)} = \\frac{E_m \\tau}{1+\\tau} $$\nThis is the expression for the maximal effect of the agonist before receptor blockade.\n\n**2. Effect of Irreversible Receptor Blockade**\n\nThe operational efficacy parameter $\\tau$ is defined as $\\tau = \\frac{e [R_T]}{K_E}$, where $e$ is the intrinsic efficacy per receptor, $[R_T]$ is the total receptor concentration, and $K_E$ is a constant representing the efficiency of signal transduction.\n\nAn irreversible antagonist reduces the number of functional receptors to a fraction $q$ of the original population. The new receptor concentration becomes $q[R_T]$. Since $e$ and $K_E$ are unchanged, the new operational efficacy, $\\tau'$, is:\n$$ \\tau' = \\frac{e (q[R_T])}{K_E} = q \\left( \\frac{e [R_T]}{K_E} \\right) = q\\tau $$\nThus, the operational efficacy is directly proportional to the receptor number.\n\nThe maximal effect after blockade, $E_{max}(\\text{after blockade})$, is found by substituting $\\tau'$ into our expression for $E_{max}$:\n$$ E_{max}(\\text{after blockade}) = \\frac{E_m \\tau'}{1+\\tau'} = \\frac{E_m (q\\tau)}{1+q\\tau} $$\n\n**3. Calculation of the Fold Retention Ratio, $R(\\tau, q)$**\n\nThe problem defines the fold retention of maximal effect as:\n$$ R(\\tau,q) = \\frac{E_{\\max}(\\text{after blockade})}{E_{\\max}(\\text{before blockade})} = \\frac{\\frac{E_m q\\tau}{1+q\\tau}}{\\frac{E_m \\tau}{1+\\tau}} $$\nCanceling the common terms $E_m$ and $\\tau$ gives:\n$$ R(\\tau,q) = \\frac{q}{1+q\\tau} \\cdot (1+\\tau) = \\frac{q(1+\\tau)}{1+q\\tau} $$\n\n**4. Computation for the Specific Agonists**\n\nWe are given $q=0.4$, $\\tau_f = 20$ (full agonist), and $\\tau_p = 0.5$ (partial agonist).\n\nFirst, we calculate $R$ for the partial agonist:\n$$ R(\\tau_p, q) = R(0.5, 0.4) = \\frac{0.4(1+0.5)}{1+(0.4)(0.5)} = \\frac{0.4(1.5)}{1+0.2} = \\frac{0.6}{1.2} = 0.5 $$\nThe maximal effect of the partial agonist is reduced to 50% of its original value.\n\nNext, we calculate $R$ for the full agonist:\n$$ R(\\tau_f, q) = R(20, 0.4) = \\frac{0.4(1+20)}{1+(0.4)(20)} = \\frac{0.4(21)}{1+8} = \\frac{8.4}{9} $$\nThe maximal effect of the full agonist is reduced to $8.4/9 \\approx 93.3\\%$ of its original value. This demonstrates the effect of receptor reserve; the full agonist had such high efficacy ($\\tau=20$) that losing 60% of the receptors barely reduced its maximal response.\n\nFinally, we compute the required ratio:\n$$ \\frac{R(\\tau_p, q)}{R(\\tau_f, q)} = \\frac{0.5}{8.4/9} = \\frac{1/2}{8.4/9} = \\frac{1}{2} \\cdot \\frac{9}{8.4} = \\frac{9}{16.8} $$\n$$ \\frac{9}{16.8} = 0.53571428... $$\nRounding to four significant figures, the value is $0.5357$.",
            "answer": "$$\n\\boxed{0.5357}\n$$"
        }
    ]
}